HealthLilly’s weight-loss pill improves sleep apnea in late-stage trial
Eli Lilly said on Monday that its oral weight-loss drug Foundayo significantly reduced sleep-time breathing interruptions among obese adults with moderate-to-severe obstructive sleep apnea, meeting the main goal of a late-stage study.
Lilly’s weight-loss pill improves sleep apnea in late-stage trial
